These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34620283)

  • 1. A century of phage therapy: from novel discoveries about the past to the challenges of the today.
    Bach-Rojecky L; Lacković Z
    Pharmazie; 2021 Oct; 76(10):519-521. PubMed ID: 34620283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vladimir Sertić: forgotten pioneer of virology and bacteriophage therapy.
    Lacković Z; Toljan K
    Notes Rec R Soc Lond; 2020 Dec; 74(4):567-578. PubMed ID: 33177747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteriophage Therapy of Urological Infections].
    Perepanova TS; Merinov DS; Kazachenko AV; Khazan PL; Malova YA
    Urologiia; 2020 Nov; (5):106-114. PubMed ID: 33185357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical data and safety assessment of phage therapy in humans.
    Nale JY; Clokie MR
    Curr Opin Biotechnol; 2021 Apr; 68():310-317. PubMed ID: 33862490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
    Boniver M; Wotquenne P; Moutschen M; Rousseau AF
    Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.
    Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE
    Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of bacteriophages against intracellular bacteria.
    Śliwka P; Ochocka M; Skaradzińska A
    Crit Rev Microbiol; 2022 Mar; 48(2):222-239. PubMed ID: 34428105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy and the public: Increasing awareness essential to widespread use.
    McCammon S; Makarovs K; Banducci S; Gold V
    PLoS One; 2023; 18(5):e0285824. PubMed ID: 37200291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European regulatory aspects of phage therapy: magistral phage preparations.
    Verbeken G; Pirnay JP
    Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice.
    Międzybrodzki R; Kasprzak H; Letkiewicz S; Rogóż P; Żaczek M; Thomas J; Górski A
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S395-S400. PubMed ID: 37932117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Therapy Takes on Broad Applications.
    Mertz L
    IEEE Pulse; 2022; 13(5):9-15. PubMed ID: 36301810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.